462 related articles for article (PubMed ID: 3275882)
41. Modification of mutagenic activities of pro-mutagens by glyco-ursodeoxycholic acid in the Ames assay.
Shibuya N; Nakamura K; Ogoshi K; Ohta T; Hori Y; Kodama K; Yamamoto M
Tohoku J Exp Med; 1999 Sep; 189(1):1-9. PubMed ID: 10622203
[TBL] [Abstract][Full Text] [Related]
42. Metabolic activation of environmental carcinogens and mutagens by human liver microsomes. Role of cytochrome P-450 homologous to a 3-methylcholanthrene-inducible isozyme in rat liver.
Shimada T; Okuda Y
Biochem Pharmacol; 1988 Feb; 37(3):459-65. PubMed ID: 3337745
[TBL] [Abstract][Full Text] [Related]
43. A model system for studying covalent binding of food carcinogens MeIQx, MeIQ and IQ to DNA and protein.
Wallin H; Alexander J
IARC Sci Publ; 1988; (89):113-7. PubMed ID: 3198193
[TBL] [Abstract][Full Text] [Related]
44. Heterocyclic aromatic amines induce DNA strand breaks and cell transformation.
Pfau W; Martin FL; Cole KJ; Venitt S; Phillips DH; Grover PL; Marquardt H
Carcinogenesis; 1999 Apr; 20(4):545-51. PubMed ID: 10223180
[TBL] [Abstract][Full Text] [Related]
45. Prostaglandin hydroperoxidase-dependent activation of heterocyclic aromatic amines.
Petry TW; Josephy PD; Pagano DA; Zeiger E; Knecht KT; Eling TE
Carcinogenesis; 1989 Dec; 10(12):2201-7. PubMed ID: 2512013
[TBL] [Abstract][Full Text] [Related]
46. Enzymatic acetylation and sulfation of N-hydroxyarylamines in bacteria and rat livers.
Yamazoe Y; Abu-Zeid M; Gong DW; Staiano N; Kato R
Carcinogenesis; 1989 Sep; 10(9):1675-9. PubMed ID: 2670304
[TBL] [Abstract][Full Text] [Related]
47. Formation of 2-nitro-3-methylimidazo[4,5-f]quinoline, a directly mutagenic product, by near-ultraviolet irradiation of a mixture of 2-amino-3-methylimidazo[4,5-f]quinoline and N-nitrosodimethylamine.
Arimoto S; Hayatsu H
Mutat Res; 1991; 250(1-2):161-7. PubMed ID: 1944331
[TBL] [Abstract][Full Text] [Related]
48. Biphasic effects of the flavonoids quercetin and naringenin on the metabolic activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline by Salmonella typhimurium TA1538 co-expressing human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and cytochrome b5.
Kang IH; Kim HJ; Oh H; Park YI; Dong MS
Mutat Res; 2004 Jan; 545(1-2):37-47. PubMed ID: 14698415
[TBL] [Abstract][Full Text] [Related]
49. Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences.
Abu-Shakra A; Ioannides C; Walker R
Mutagenesis; 1986 Sep; 1(5):367-70. PubMed ID: 3331675
[TBL] [Abstract][Full Text] [Related]
50. Mutagenic activity of the methyl and phenyl derivatives of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoxaline (IQx) in the Ames test.
Vikse R; Knapstad A; Klungsøyr L; Grivas S
Mutat Res; 1993 Jan; 298(3):207-14. PubMed ID: 7678155
[TBL] [Abstract][Full Text] [Related]
51. Fluorometric detection of 2-amino-3-methylimidazo[4,5-f]quinoline, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline and their N-acetylated metabolites excreted by the rat.
Størmer FC; Alexander J; Becher G
Carcinogenesis; 1987 Sep; 8(9):1277-80. PubMed ID: 3621465
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of Escherichia coli DJ4309 expressing human P450 1A2 in mutagenicity testing of complex food mixtures.
Constable A; Varga N; Josephy PD; Guy P; Turesky RJ
Mutat Res; 1999 Jun; 442(2):79-87. PubMed ID: 10393276
[TBL] [Abstract][Full Text] [Related]
53. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
[TBL] [Abstract][Full Text] [Related]
54. Induction of unscheduled DNA synthesis in rat and hamster hepatocytes by cooked food mutagens.
Howes AJ; Beamand JA; Rowland IR
Food Chem Toxicol; 1986 May; 24(5):383-7. PubMed ID: 3744191
[TBL] [Abstract][Full Text] [Related]
55. Prostaglandin H synthase-dependent formation of the direct-acting mutagen 2-nitro-3-methylimidazo[4,5-f]quinoline (nitro-IQ) from IQ.
Morrison LD; Eling TE; Josephy PD
Mutat Res; 1993 May; 302(1):45-52. PubMed ID: 7683106
[TBL] [Abstract][Full Text] [Related]
56. Metabolism of 2-amino-3-methylimidazo[4,5-f]quinoline IQ and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) in suspensions of isolated rat-liver cells.
Holme JA; Alexander J; Becher G; Trygg B
Toxicol In Vitro; 1987; 1(4):175-81. PubMed ID: 20702361
[TBL] [Abstract][Full Text] [Related]
57. Effect of methyl substitution on mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline, isolated from broiled sardine.
Nagao M; Wakabayashi K; Kasai H; Nishimura S; Sugimura T
Carcinogenesis; 1981; 2(11):1147-9. PubMed ID: 7032742
[TBL] [Abstract][Full Text] [Related]
58. Mutagenicity of nitro derivatives produced by exposure of dibenzofuran to nitrogen oxides.
Watanabe T; Hirayama T
Mutat Res; 1992 Sep; 283(1):35-43. PubMed ID: 1380661
[TBL] [Abstract][Full Text] [Related]
59. Enhancement of the mutagenicity of IQ and MeIQ by nitrite in the Salmonella system.
Lin JK; Cheng JT; Lin-Shiau SY
Mutat Res; 1992 Apr; 278(4):277-87. PubMed ID: 1373865
[TBL] [Abstract][Full Text] [Related]
60. Structure-activity relationships of anthraquinones as inhibitors of 7-ethoxycoumarin O-deethylase and mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline.
Hao NJ; Huang MP; Lee H
Mutat Res; 1995 May; 328(2):183-91. PubMed ID: 7739602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
